eResearchTechnology, Inc. Clinical Research
 



EXECUTIVE MANAGEMENT TEAM

Officers are elected by the Board of Directors and serve at
the pleasure of the Board. Our executive officers are as follows:


 Name   Position
 Michael J. McKelvey, MA, PH.D   President and Chief Executive Officer
 Joel Morganroth, MD   Chairman and Chief Scientist
 Richard A. Baron   Executive Vice President and Chief Financial Officer
 Thomas P. Devine   Executive Vice President and Chief Development Officer
 Amy Furlong   Executive Vice President, Cardiac Safety Operations
 Jeffrey S. Litwin, MD   Executive Vice President and Chief Medical Officer
 John M. Blakeley   Senior Vice President, International Operations and Sales
 Robert S. Brown   Senior Vice President, Strategic Marketing, Planning and Partnerships
 George Tiger   Senior Vice President, Americas Sales

Dr. McKelvey has served as our President and CEO since June 2006. Prior to that, he had been employed by PAREXEL International, one of the largest biopharmaceutical outsourcing organizations in the world, where he has served as Corporate Senior Vice President, Clinical Research Services (CRS). He is responsible for the CRS Americas clinical operations in addition to being in charge of the worldwide data management and biostatistics and programming activities for CRS.

Prior to PAREXEL, Dr. McKelvey owned and operated his own firm, McKelvey, LLC, which provided strategic consulting for organizations on e-business strategy, product development, and marketing. He spent six years with ICF Consulting as Executive Vice President and President -- ICF Information Technology, Inc. In 1999, he participated in the management-led buyout of ICF Consulting from its then-parent ICF Kaiser International. Dr. McKelvey was with DRI/McGraw-Hill for 10 years in a variety of executive roles in the technology consulting and information management areas. He spent the first 10 years of his career with the U.S. Department of Commerce, where he served as Forecast Manager and Senior Economist in the Bureau of Economic Analysis. Dr. McKelvey holds a Ph.D. and M.A. from the Wharton School, University of Pennsylvania and an A.B. degree from Williams College.

Dr. Morganroth has served as the Chairman of our Board of Directors since 1999 and a member of our Board of Directors since 1997. He has served as our Chief Scientific Officer since April 2006. Prior to that, he served as our Chief Scientist from March 2001 to December 2005 and our Chief Executive Officer from 1993 to March 2001. In addition, Dr. Morganroth has consulted for us since 1977. Dr. Morganroth is a globally recognized cardiologist and clinical researcher. Dr. Morganroth served for over ten years as a Medical Review Officer/Expert for the U.S. Food and Drug Administration.

Mr. Baron has served as our Executive Vice President and Chief Financial Officer since May 2006. Prior to that, Mr. Baron served as Vice President Finance and Chief Financial Officer for Animas Corporation, a manufacturer and distributor of insulin infusion pumps. He was instrumental in leading Animas' initial public offering in May 2004. Animas was recently acquired by Johnson & Johnson. Prior to joining Animas, Mr. Baron served as Chief Financial Officer of three other corporations, including a pharmaceutical company. He spent 11 years in public accounting primarily with Coopers & Lybrand. Mr. Baron is a certified public accountant with a degree from the Wharton School of the University of Pennsylvania.

Mr. Devine has served as our Executive Vice President and Chief Development Officer since December 2005. Prior to that he served since 2003 as Senior Vice President and Chief Development Officer and since 2002 as Vice President, R&D. Mr. Devine was previously employed by ecHUB as Chief Technology Officer from 2000 to 2002 and prior to that Mr. Devine spent 18 years in IBM and Lockheed Martin in Senior Director level technology positions.

Ms. Furlong has served as our Executive Vice President, Cardiac Safety Operations since December 2005. Previously, she served as our Senior Vice President, Regulatory Compliance since January 2004. From February 2001 to January 2004, Ms. Furlong served as our Vice President, Regulatory Compliance and from February 1999 to February 2001, she served as our Sr. Director, Regulatory Compliance, Ms Furlong has been employed with eResearchTechnology for 11 years.

Dr. Litwin is a cardiologist and has served as our Executive Vice President and Chief Medical Officer since December 2005. Previously, he served as our Senior Vice President and Chief Medical Officer since July 2000. Dr. Litwin was employed by Executive Health Group, a leading international provider of physical examinations for corporate executives, from May 1993 to July 2000, most recently as Executive Vice President and Chief Operating Officer. Dr. Litwin also served as a consultant for Schlumberger, Ltd. from March 1996 to July 2000 and for the American and National League of Professional Baseball Clubs from April 1995 to March 1999.

Mr. Blakeley has been our Senior Vice President, International Operations and Sales since September 2006. He served as our Group Vice President, International Business Development from January 2005 to August 2006 and as our Director of Business Development from May 2002 to December 2004. Prior to joining eRT, Mr. Blakeley was Managing Director of MediServe Medical UK Limited, a medical devices specialist.

Mr. Brown has been our Senior Vice President, Strategic Marketing, Planning & Partnerships since September 2006. Prior to this, Mr. Brown served as our Senior Vice President, Outsourcing Partnerships from July 2002 to August 2006. From January 2000 to June 2002, Mr. Brown was our Senior Vice President, Cardiac Safety. Mr. Brown has been employed with us for over 24 years.

Mr. Tiger has been our Senior Vice President, Americas Sales since October 2006. He served as our Senior Vice President, International Sales and Operations from October 2005 to September 2006, Senior Vice President, International Operations from July 2004 to October 2005, Vice President, International Business Development from August 2002 to July 2004 and as Director of Business Development from January 2001 to August 2002.